246 related articles for article (PubMed ID: 9520352)
1. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
[TBL] [Abstract][Full Text] [Related]
2. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Carcinogenesis; 1995 Aug; 16(8):1723-31. PubMed ID: 7634396
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Toxicology; 1997 Nov; 123(1-2):125-34. PubMed ID: 9347927
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in the metabolism of 1,3-butadiene in Sprague-Dawley rats following a low level inhalation exposure.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Pei L; Henderson RF
Carcinogenesis; 1995 Nov; 16(11):2875-8. PubMed ID: 7586213
[TBL] [Abstract][Full Text] [Related]
6. Gender and species differences in the metabolism of 1,3-butadiene to butadiene monoepoxide and butadiene diepoxide in rodents following low-level inhalation exposures.
Thornton-Manning JR; Dahl AR; Bechtold WE; Henderson RF
Toxicology; 1996 Oct; 113(1-3):322-5. PubMed ID: 8901918
[TBL] [Abstract][Full Text] [Related]
7. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry and acute toxicity of inhaled butadiene diepoxide in rats and mice.
Henderson RF; Hahn FF; Benson JM; Barr EB; Bechtold WE; Burt DG; Dahl AR
Toxicol Sci; 1999 Sep; 51(1):146-52. PubMed ID: 10496686
[TBL] [Abstract][Full Text] [Related]
9. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
10. 1,3-butadiene: cancer, mutations, and adducts. Part I: Carcinogenicity of 1,2,3,4-diepoxybutane.
Henderson RF; Barr EB; Belinsky SA; Benson JM; Hahn FF; Ménache MG
Res Rep Health Eff Inst; 2000 Mar; (92):11-43; discussion 45-8. PubMed ID: 10925838
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenicity of inhaled butadiene diepoxide in female B6C3F1 mice and Sprague-Dawley rats.
Henderson RF; Hahn FF; Barr EB; Belinsky SA; Ménache MG; Benson JM
Toxicol Sci; 1999 Nov; 52(1):33-44. PubMed ID: 10568696
[TBL] [Abstract][Full Text] [Related]
12. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
13. Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells.
Meng RQ; Hackfeld LC; Hedge RP; Wisse LA; Redetzke DL; Walker VE;
Res Rep Health Eff Inst; 2010 Jun; (150):1-34; discussion 35-41. PubMed ID: 20853577
[TBL] [Abstract][Full Text] [Related]
14. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene.
Himmelstein MW; Asgharian B; Bond JA
Toxicol Appl Pharmacol; 1995 Jun; 132(2):281-8. PubMed ID: 7785055
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of the racemic mixtures of butadiene monoepoxide and butadiene diepoxide at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
Meng Q; Henderson RF; Walker DM; Bauer MJ; Reilly AA; Walker VE
Mutat Res; 1999 Aug; 429(1):127-40. PubMed ID: 10434028
[TBL] [Abstract][Full Text] [Related]
16. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
[TBL] [Abstract][Full Text] [Related]
17. Analysis of butadiene, butadiene monoxide, and butadiene dioxide in blood by gas chromatography/gas chromatography/mass spectroscopy.
Bechtold WE; Strunk MR; Thornton-Manning JR; Henderson RF
Chem Res Toxicol; 1995 Mar; 8(2):182-7. PubMed ID: 7766800
[TBL] [Abstract][Full Text] [Related]
18. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
Booth ED; Kilgour JD; Robinson SA; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
Csanády GA; Guengerich FP; Bond JA
Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
[TBL] [Abstract][Full Text] [Related]
20. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
